IP Library Granted Patent US 10,961,574
Granted Patent B2
US 10,961,574 · App. 16/674,341 · Granted Mar 30, 2021

Methods and compositions for incorporating nucleotides

Inventors: Steven Gordon (Weston, MA); Jerzy Olejnik (Brookline, MA)
Assignee: QIAGEN SCIENCES, LLC
C12Q1/6869C07H19/00C12Q1/6874G01N21/05G01N21/645G01N21/6428C12Q2535/101G01N2021/0346G01N2021/058G01N2021/6417G01N2021/6419G01N2021/6421G01N2021/6439G01N2021/6441G01N2021/6471G01N2201/062G01N2201/0627G01N2201/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,961,574
App. No.
16/674,341
Granted
Mar 30, 2021
Kind
B2
Abstract

The invention provides methods and compositions, including, without limitation, algorithms, computer readable media, computer programs, apparatus, and systems for determining the identity of nucleic acids in nucleotide sequences using, for example, data obtained from sequencing by synthesis methods. The methods of the invention include correcting one or more phenomena that are encountered during nucleotide sequencing, such as using sequencing by synthesis methods. These phenomena include, without limitation, sequence lead, sequence lag, spectral crosstalk, and noise resulting from variations in illumination and/or filter responses.

Claims (27)

1. A method for determining an identity of a nucleotide at a position, comprising: a) providing nucleic acid, polymerase, and a mixture of labeled and non-labeled reversible terminators, said labeled reversible terminators comprising a label linked to a nucleotide analogue, said label producing color, wherein the label is Rhodamine 6G and is attached to the nucleotide analogue of dUTP though a cleavable linker and wherein a removable chemical moiety caps the 3′-O group, wherein said labeled reversible terminator is in a mixture in solution with an unlabeled reversible terminator comprising a nucleotide analogue of dUTP, wherein the concentration of the unlabeled nucleotide analogue of dUTP is present in said solution at a higher concentration than the labeled nucleotide analogue of dUTP; b) incorporating, with said polymerase, a first nucleotide analogue from said mixture into said nucleic acid at a position; and c) detecting the label of said incorporated first nucleotide analogue.

2. The method of claim 1 , wherein said detecting is done with a device.

3. The method of claim 2 , wherein said device measures color in more than one detector channel.

4. The method of claim 3 , wherein said color detected in two channels.

5. The method of claim 1 , wherein said cleavable linker comprises a disulfide bond.

6. The method of claim 1 , further comprising d) determining the identity of the incorporated nucleotide at said position.

7. The method of claim 1 , wherein said mixture further comprises labeled and unlabeled reversible terminator nucleotide analogues of dCTP and dGTP.

8. The method of claim 7 , wherein said unlabeled nucleotide analogues are present at a concentration between 1 uM and 100 uM.

9. The method of claim 8 , wherein said labeled nucleotide analogues are present at a concentration between 1 nM and 1 uM.

10. A method for determining an identity of a nucleotide at a position, comprising: a) providing nucleic acid, polymerase, and a mixture of labeled and non-labeled reversible terminators, said labeled reversible terminators comprising a label linked to a nucleotide analogue, said label producing color, wherein the label is Cy5 and is attached to the nucleotide analogue of dGTP though a cleavable linker and wherein a removable chemical moiety caps the 3′-O group, wherein said labeled reversible terminator is in a mixture in solution with an unlabeled reversible terminator comprising a nucleotide analogue of dGTP, wherein the concentration of the unlabeled nucleotide analogue of dGTP is present in said solution at a higher concentration than the labeled nucleotide analogue of dGTP; b) incorporating, with said polymerase, a first nucleotide analogue from said mixture into said nucleic acid at a position; and c) detecting the label of said incorporated first nucleotide analogue.

11. The method of claim 10 , wherein said detecting is done with a device.

12. The method of claim 11 , wherein said device-measures color in more than one detector channel.

13. The method of claim 12 , wherein said color detected in two channels.

14. The method of claim 10 , wherein said cleavable linker comprises a disulfide bond.

15. The method of claim 10 , further comprising d) determining the identity of the incorporated nucleotide at said position.

16. The method of claim 10 , wherein said mixture further comprises labeled and unlabeled reversible terminator nucleotide analogues of dCTP and dATP.

17. The method of claim 16 , wherein said unlabeled nucleotide analogues are present at a concentration between 1 uM and 100 uM.

18. The method of claim 17 , wherein said labeled nucleotide analogues are present at a concentration between 1 nM and 1 uM.

19. A method for determining an identity of a nucleotide at a position, comprising: a) providing nucleic acid, polymerase, and a mixture of labeled and non-labeled reversible terminators, said labeled reversible terminators comprising a label linked to a nucleotide analogue, said label producing color, wherein the label is ROX and is attached to the nucleotide analogue of dATP though a cleavable linker and wherein a removable chemical moiety caps the 3′-O group, wherein said labeled reversible terminator is in a mixture in solution with an unlabeled reversible terminator comprising a nucleotide analogue of dATP, wherein the concentration of the unlabeled nucleotide analogue of dATP is present in said solution at a higher concentration than the labeled nucleotide analogue of dATP; b) incorporating, with said polymerase, a first nucleotide analogue from said mixture into said nucleic acid at a position; and c) detecting the label of said incorporated first nucleotide analogue.

20. The method of claim 19 , wherein said detecting is done with a device.

21. The method of claim 20 , wherein said device-measures color in more than one detector channel.

22. The method of claim 21 , wherein said color detected in two channels.

23. The method of claim 19 , wherein said cleavable linker comprises a disulfide bond.

24. The method of claim 19 , further comprising d) determining the identity of the incorporated nucleotide at said position.

25. The method of claim 19 , wherein said mixture further comprises labeled and unlabeled reversible terminator nucleotide analogues of dCTP and dGTP.

26. The method of claim 25 , wherein said unlabeled nucleotide analogues are present at a concentration between 1 uM and 100 uM.

27. The method of claim 26 , wherein said labeled nucleotide analogues are present at a concentration between 1 nM and 1 uM.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2023
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: ISOPLEXIS CORPORATION
Reel/Frame 063235/0942 →
PATENT PURCHASE AGREEMENT Recorded Jul 30, 2021
From: QIAGEN SCIENCES, LLC
To: ISOPLEXIS CORPORATION
Reel/Frame 057043/0629 →
SECURITY AGREEMENT Recorded May 28, 2021
From: ISOPLEXIS CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 056421/0929 →
MERGER Recorded Nov 18, 2019
From: QIAGEN WALTHAM, INC.
To: QIAGEN SCIENCES, LLC
Reel/Frame 051044/0268 →
CHANGE OF NAME Recorded Nov 15, 2019
From: INTELLIGENT BIO-SYSTEMS, INC.
To: QIAGEN WALTHAM, INC.
Reel/Frame 051027/0112 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2019
From: OLEJNIK, JERZY; GORDON, STEVEN
To: INTELLIGENT BIO-SYSTEMS, INC.
Reel/Frame 051007/0658 →
Continuity (8)
Continuation 16193639 · Nov 16, 2018
Continuation 15480043 · Apr 5, 2017
Continuation 15144079 · May 2, 2016
Continuation 14518114 · Oct 20, 2014
Division 13305415 · Nov 28, 2011
Continuation 12405779 · Mar 17, 2009
Provisional Application 61037845 · Mar 19, 2008
Related Publication 20200071755A1 · Mar 5, 2020
Cited By (2)
US 12,227,798 US 12,656,313